LPL Financial
ONC

LPL Financial’s BeOne Medicines Ltd ONC Stock Holding History

LPL Financial’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
6,043
+1,159
+24% +$342K ﹤0.01% 3911
2026
Q1 		$1.45M Buy
4,884
+819
+20% +$265K ﹤0.01% 3816
2025
Q4 		$1.23M Buy
4,065
+529
+15% +$173K ﹤0.01% 3853
2025
Q3 		$1.2M Buy
3,536
+655
+23% +$199K ﹤0.01% 3819
2025
Q2 		$697K Buy
2,881
+551
+24% +$135K ﹤0.01% 4087
2025
Q1 		$634K Buy
2,330
+321
+16% +$75K ﹤0.01% 3945
2024
Q4 		$371K Buy
2,009
+110
+6% +$22.5K ﹤0.01% 4341
2024
Q3 		$426K Buy
1,899
+287
+18% +$51.6K ﹤0.01% 4132
2024
Q2 		$230K Sell
1,612
-44
-3% -$6.78K ﹤0.01% 4458
2024
Q1 		$259K Sell
1,656
-352
-18% -$56.7K ﹤0.01% 4322
2023
Q4 		$362K Sell
2,008
-25
-1% -$4.52K ﹤0.01% 3936
2023
Q3 		$366K Buy
2,033
+73
+4% +$14.4K ﹤0.01% 3744
2023
Q2 		$349K Buy
1,960
+20
+1% +$4.61K ﹤0.01% 3722
2023
Q1 		$418K Buy
1,940
+210
+12% +$50.4K ﹤0.01% 3483
2022
Q4 		$380K Buy
1,730
+195
+13% +$35.8K ﹤0.01% 3484
2022
Q3 		$207K Sell
1,535
-81
-5% -$13.9K ﹤0.01% 3906
2022
Q2 		$262K Sell
1,616
-222
-12% -$34.7K ﹤0.01% 3734
2022
Q1 		$347K Sell
1,838
-449
-20% -$95.5K ﹤0.01% 3469
2021
Q4 		$620K Sell
2,287
-202
-8% -$68.2K ﹤0.01% 3089
2021
Q3 		$904K Buy
2,489
+746
+43% +$244K ﹤0.01% 2696
2021
Q2 		$598K Buy
1,743
+504
+41% +$167K ﹤0.01% 2998
2021
Q1 		$431K Buy
1,239
+185
+18% +$61.3K ﹤0.01% 3153
2020
Q4 		$272K Buy
1,054
+71
+7% +$19.5K ﹤0.01% 3287
2020
Q3 		$282K Buy
+983
New +$231K ﹤0.01% 2948

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LPL Financial's ONC Position: Q2 2026 in Review

LPL Financial increased its BeOne Medicines Ltd (ONC) stake by 24% in Q2 2026, buying an estimated $342K and bringing the position to 6,043 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #3911.

LPL Financial first reported a position in ONC in Q3 2020 and has held it in 24 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • LPL Financial held 6,043 shares of BeOne Medicines Ltd worth $1.72M as of Q2 2026.
  • LPL Financial bought 1,159 BeOne Medicines Ltd shares in Q2 2026, an estimated $342K.
  • BeOne Medicines Ltd made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3911 holding.
  • LPL Financial first reported a position in BeOne Medicines Ltd in Q3 2020 and has held it in 24 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.